
EFSA: ‘No link between Nestlé infant formula consumption and reduced dermatitis risk’
The European Food and Safety Authority (EFSA) has rejected claims a peptide blend included in infant formula could reduce the risk of developing atopic dermatitis.
News, Analysis & Insights on Nutrition, Supplements, and Health
The European Food and Safety Authority (EFSA) has rejected claims a peptide blend included in infant formula could reduce the risk of developing atopic dermatitis.
This round-up will look at the strategies of big brands BYHEALTH, HempFusion, Vital Proteins, and Tipco in expanding their market reach and developing new nutritional products.